JIN-A02

N/A

Report date: 2022/12/04 16:30:26
NME

Base Information

Drug NameJIN-A02
Drug Alias NameJIN-A02JIN-A-02
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEGFR C797S inhibitors
TargetsEGFR C797S
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesThailandSouth Korea
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesJ INTS BIO Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJ INTS BIO Co Ltd
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A